Write a medical clearance note for a 26‑year‑old male service member with obesity, hypertension, hyperlipidemia, and pre‑diabetes who was referred for abnormal labs, include separate Review of Systems and Physical Examination sections, note extensive lifestyle counseling, and state that he will complete a five‑day home blood‑pressure monitoring program before clearance can be granted.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Clearance Note

PATIENT INFORMATION:
26-year-old male service member presenting for medical clearance following abnormal laboratory findings.

CHIEF CONCERN:
Referred for evaluation of elevated blood glucose, dyslipidemia, hypertension, and obesity.

ASSESSMENT & PLAN

This patient cannot be cleared for duty at this time. He requires completion of a 5-day home blood pressure monitoring protocol and implementation of comprehensive lifestyle modifications before medical clearance can be granted. 1, 2

1. Hypertension – Stage 1, Newly Diagnosed

Blood Pressure: 142/91 mmHg (measured today in office)

Chart review reveals a pattern of elevated readings in the past, though the patient was unaware of this history. 1, 2

Diagnostic Confirmation Required:

  • Home blood pressure monitoring for 5 consecutive days is mandatory before clearance. 1, 2
  • Patient instructed to measure BP twice daily (morning and evening) after sitting quietly for 5 minutes with back supported and feet flat on floor. 2
  • Home BP ≥135/85 mmHg will confirm true hypertension requiring treatment. 1, 2
  • This approach excludes white-coat hypertension and establishes baseline severity. 1, 2

Management Plan:

  • Lifestyle modifications are the first-line treatment and were extensively counseled today: 1

    • Sodium restriction to <2 g/day (expect 5-10 mmHg systolic reduction) 1
    • DASH dietary pattern (expect 11.4/5.5 mmHg reduction) 1
    • Weight loss of 10 kg target (expect 6.0/4.6 mmHg reduction) 1
    • Aerobic exercise ≥150 minutes/week (expect 4/3 mmHg reduction) 1
    • Alcohol limitation to ≤2 drinks/day for men 1

  • If home BP confirms ≥135/85 mmHg, pharmacological treatment will be initiated at follow-up visit. 1

  • Target BP: <130/80 mmHg given multiple cardiovascular risk factors (obesity, pre-diabetes, dyslipidemia). 1

  • First-line agent will be either an ACE inhibitor/ARB or calcium channel blocker, combined with lifestyle therapy. 1

2. Pre-Diabetes

Hemoglobin A1c: 5.8% (initial) → 5.9% (repeat 3 days later)
Fasting glucose status: Elevated per referring provider

Both A1c values fall in the pre-diabetes range (5.7-6.4%), indicating impaired glucose regulation. 1

Management Plan:

  • Lifestyle intervention is the cornerstone of pre-diabetes management and can delay/prevent progression to type 2 diabetes. 1
  • Patient referred to "Sugar Smarts" class as recommended by previous provider. 1
  • Specific dietary counseling provided today: 1
    • Eliminate sugary beverages completely 1
    • Limit processed carbohydrates 1
    • Reduce alcohol intake 1
    • Adopt Mediterranean-style eating pattern rich in vegetables, legumes, fruits, and whole grains 1
  • Weight loss of 7-10% body weight (current BMI 36) is critical—even modest loss significantly reduces diabetes risk. 1, 3
  • Repeat A1c in 3 months to assess response to lifestyle modifications. 1

3. Dyslipidemia – Atherogenic Pattern

Initial labs:

  • LDL: 107 mg/dL
  • HDL: 39 mg/dL (low)
  • Triglycerides: 223 mg/dL (elevated)
  • Total cholesterol: 185 mg/dL

Repeat labs (3 days later):

  • LDL: 159 mg/dL (significantly increased)
  • HDL: 45 mg/dL (improved but still suboptimal)
  • Triglycerides: 129 mg/dL (improved)
  • Total cholesterol: 230 mg/dL

The discrepancy between the two lab sets likely reflects non-fasting vs. fasting status or laboratory variation, as noted by the patient's confusion about duplicate testing. 1

Management Plan:

  • Lifestyle modifications are first-line therapy: 1
    • Mediterranean diet supplemented with olive oil and/or nuts reduces cardiovascular events 1
    • Weight loss improves all lipid parameters 1, 3
    • Increased physical activity raises HDL and lowers triglycerides 1, 3
  • Target goals: 1
    • LDL <100 mg/dL minimum (ideally <70 mg/dL given multiple risk factors) 1
    • HDL >40 mg/dL for men 1
    • Triglycerides <150 mg/dL 1
  • Statin therapy may be considered if LDL remains >130 mg/dL after 3 months of lifestyle intervention, especially given pre-diabetes and hypertension. 1
  • Repeat fasting lipid panel in 3 months. 1

4. Obesity – Class II (BMI 36)

Obesity is the central driver of this patient's metabolic derangements (hypertension, pre-diabetes, dyslipidemia). 3, 4, 5

Management Plan:

  • Reduced calorie intake is mandatory to lower excessive body weight. 1, 3
  • Target: 7-10% weight loss (approximately 15-22 lbs) over 6 months. 1, 3
  • This modest weight loss will: 1, 3
    • Reduce A1c and delay diabetes progression 1, 3
    • Lower blood pressure by 6/4.6 mmHg 1
    • Improve lipid profile (decrease LDL and triglycerides, increase HDL) 1, 3
  • Moderate-to-vigorous physical activity ≥150 minutes/week is recommended for prevention and control of diabetes and hypertension. 1, 3
  • Patient extensively counseled on the interconnected nature of his conditions—addressing obesity will simultaneously improve all metabolic parameters. 3, 4, 5

REVIEW OF SYSTEMS

Constitutional: Denies fever, chills, night sweats, unintentional weight changes
Cardiovascular: Denies chest pain, palpitations, orthopnea, paroxysmal nocturnal dyspnea, lower extremity edema
Respiratory: Denies shortness of breath, cough, wheezing
Gastrointestinal: Denies abdominal pain, nausea, vomiting, diarrhea, constipation
Genitourinary: Denies dysuria, hematuria, polyuria, nocturia
Neurological: Denies headache, dizziness, syncope, visual changes, weakness, numbness, tingling
Endocrine: Denies polydipsia, polyphagia, heat/cold intolerance
Musculoskeletal: Denies joint pain, muscle weakness
Psychiatric: Denies depression, anxiety

PHYSICAL EXAMINATION

Vital Signs:

  • Blood Pressure: 142/91 mmHg (right arm, seated, appropriate cuff size)
  • Heart Rate: [not documented]
  • Respiratory Rate: [not documented]
  • Temperature: [not documented]
  • BMI: 36 kg/m² (Class II Obesity)

General: Alert, oriented, no acute distress
HEENT: Normocephalic, atraumatic; pupils equal, round, reactive to light; oropharynx clear
Neck: Supple, no jugular venous distension, no thyromegaly
Cardiovascular: Regular rate and rhythm, normal S1/S2, no murmurs, rubs, or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi
Abdomen: Soft, non-tender, non-distended, no hepatosplenomegaly, normal bowel sounds
Extremities: No edema, pulses 2+ bilaterally, no cyanosis or clubbing
Neurological: Cranial nerves II-XII intact, strength 5/5 in all extremities, sensation intact, reflexes 2+ and symmetric

DISPOSITION

Medical clearance DEFERRED pending:

  1. Completion of 5-day home blood pressure monitoring protocol 1, 2
  2. Return visit in 1 week with BP log for review and treatment decision 1, 2

Patient extensively counseled on:

  • Critical importance of lifestyle modifications (diet, exercise, weight loss, sodium restriction, alcohol limitation) 1
  • Proper home BP measurement technique 2
  • Enrollment in "Sugar Smarts" class for pre-diabetes education 1
  • Interconnected nature of obesity, hypertension, pre-diabetes, and dyslipidemia 3, 4, 5
  • High cardiovascular risk if conditions remain uncontrolled 1, 4

Patient verbalized understanding and agreed to the plan.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Diagnosing Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a 61‑year‑old man with HTN (hypertension), IHD (ischemic heart disease), former smoker, and BMI (body mass index) 31 kg/m² presenting with exertional dyspnea and limited walking, which factor poses the greatest risk to his condition: HTN and obesity, smoking history, or age‑related activity limitation?
A 65-year-old female with a history of type 2 diabetes mellitus (on insulin), poorly controlled hypertension, and hyperlipidemia presents to the emergency department with chest discomfort, nausea, sweating, and mild shortness of breath that started 30 minutes ago, what is the diagnosis and management plan for this patient?
What is the appropriate management for a patient with uncontrolled diabetes, hypertension, hyperlipidemia, and mildly elevated liver enzymes?
What is the best course of management for a patient with severe hyperglycemia, hypertension, and possible urinary tract infection, who is also known to have BPH, DM on insulin, and HTN, and is currently presenting with lower abdominal pain, vomiting, and is on Foley catheterization?
What is the best management plan for a patient with hypertension, dyslipidemia, impaired glucose regulation, and subclinical hyperthyroidism?
What measures can be taken to prevent aspiration pneumonitis in an intubated patient, especially if they have a history of gastro‑esophageal disease?
What is the maximum dose of intravenous labetalol infusion in a 24‑hour period for an adult?
What are the safe analgesic options for a pregnant woman experiencing severe non‑opioid‑related pain?
In a patient with metastatic nasopharyngeal carcinoma with meningeal metastases, which programmed death‑1 (PD‑1) inhibitor—tislelizumab or pembrolizumab—should be used as first‑line therapy, and what is the recommended gemcitabine‑cisplatin chemotherapy regimen and dosing?
What is the most common form of male‑pattern androgenetic alopecia and its first‑line therapy?
What is the best option to offset the weight gain associated with quetiapine in a patient with bipolar depression on lithium who also has insomnia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question